SCHEMBL3852907

SCHEMBL3852907

O=C(O)c1cccc(N2CCN(c3ncnc4ccc(-c5ccn(C(c6ccccc6)(c6ccccc6)c6ccccc6)n5)cc34)CC2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 12/20 0.43
HPGD P15428 4/20 0.43
ALDH1A1 P00352 12/20 0.41
CLK4 Q9HAZ1 11/20 0.41
CYP1A2 P05177 10/20 0.41
HIF1A Q16665 8/20 0.41
TSHR P16473 8/20 0.41
LMNA P02545 8/20 0.41
MAPK1 P28482 7/20 0.41
USP2 O75604 5/20 0.41
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
CYP2C19 P33261 8/20 0.41
CYP2D6 P10635 5/20 0.41
HSD17B10 Q99714 6/20 0.40
KDM4E B2RXH2 4/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CNR1 P21554 1/20 0.39
CNR2 P34972 1/20 0.39
GAA P10253 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3852147 0.89 RPS6KB1 (0.48) CYP3A4HPGDALDH1A1CLK4CYP1A2
SCHEMBL3855018 0.88 PDGFRB (0.45) CYP3A4HPGDTSHRSMN1; SMN2TP53
SCHEMBL3853439 0.85 CLK4 (0.42) CYP3A4HPGDALDH1A1CLK4CYP1A2
SCHEMBL3848199 0.82 CYP3A4 (0.45) CYP3A4HPGDALDH1A1CLK4CYP1A2
SCHEMBL3846607 0.81 CYP3A4 (0.59) CYP3A4HPGDALDH1A1CLK4CYP1A2
SCHEMBL4716051 0.77 CLK4 (0.43) CYP3A4HPGDALDH1A1CLK4CYP1A2
SCHEMBL3852434 0.76 ACHE (0.52) CYP3A4HPGDALDH1A1CLK4CYP1A2
SCHEMBL3855143 0.75 CYP3A4 (0.40) CYP3A4HPGDALDH1A1CLK4CYP1A2
SCHEMBL5852369 0.74 CYP1A2 (0.43) CYP3A4HPGDALDH1A1CLK4CYP1A2
SCHEMBL4761308 0.73 SIRT2 (0.42) CYP3A4ALDH1A1CLK4CYP1A2HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed